| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 03/15/2006 | EP1633720A1 Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
| 03/15/2006 | EP1633711A1 Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo [3,1,0] hexane-2-carboxylates or salts thereof |
| 03/15/2006 | EP0997147B1 Amino acid derivatives |
| 03/15/2006 | CN1747926A Substituted amides |
| 03/15/2006 | CN1245376C Substituted 2-dialkylamino alkylbiphenyl derivatives |
| 03/14/2006 | US7012161 Compound, fluorine-containing polymerizable cyclic olefin compound |
| 03/14/2006 | US7012160 Fluorine-containing acetophenone derivative, surface layer material containing the same as photo initiator, article with composite hard coat layer, and method for forming composite hard coat layer |
| 03/14/2006 | US7012159 Phenolic compounds and recording materials containing the same |
| 03/14/2006 | US7012152 Reduction of 2-amino-6-methyl-6-nitroheptanoic acid |
| 03/14/2006 | US7012151 the highly regioselective aromatic nitration of alkyl 4-alkanoylamino-3-alkyl-benzoates in the 5-position in a mixture containing nitric acid |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 03/14/2006 | CA2256396C Process for producing optically active amines |
| 03/14/2006 | CA2147984C Butenyl-substituted taxanes and composition |
| 03/14/2006 | CA2135138C Method for producing formic acid or its derivatives |
| 03/10/2006 | CA2518664A1 Saturated and unsaturated n-alkamides exhibiting taste and flavor enhancement effect in flavor compositions |
| 03/09/2006 | WO2006026747A2 Diphenylethylene compounds and uses thereof |
| 03/09/2006 | WO2006025269A1 Novel polyacetylene derivatives |
| 03/09/2006 | WO2006024783A1 Method for acylating nucleophilic compounds in particular anilines |
| 03/09/2006 | WO2006024523A1 Phthalamide derivatives for use as insecticides |
| 03/09/2006 | WO2006024388A1 Method for the production of biphenylamines |
| 03/09/2006 | WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 03/09/2006 | US20060052600 Amino-functional chalcones |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052315 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 03/09/2006 | US20060051303 lower toxicity to the body, a higher degree of safety, and an equal or better UV ray protection effect; naphthyl or benzyl carboxylate derivatives |
| 03/09/2006 | CA2578772A1 Diphenylethylene compounds and uses thereof |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1632236A1 Inhibitors of the anandamide transporter |
| 03/08/2006 | EP1631540A2 Prodrugs of selective androgen receptor modulators and methods of use thereof |
| 03/08/2006 | EP1631260A2 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 03/08/2006 | EP1039902B1 Inhibitors of gap junction communication |
| 03/08/2006 | EP0771190B1 Lock and key micelles |
| 03/08/2006 | CN1244569C C-10 position taxane derivative and its medicine composition |
| 03/08/2006 | CN1244548C Device and method for dual-flow tray type gas carried evaporation concentration of acrylamide solution |
| 03/07/2006 | US7009078 halogenating in the 5-position and hydroxylating in the 4-position under lactonization, replacing halogen with azide, amidating lactone, then transferring the azide to the amine group |
| 03/07/2006 | US7009065 bidentate organophosphorous ferrocenyl ligands that create a highly asymmetric coordination sphere |
| 03/07/2006 | US7009030 an iron alloy and a reaction product of a C6 C12 linear dicarboxylic acid; and a diamine of formula H2N(CH2)nNH2, wherein n is an integer from 2 to 6, and the molar ratio of said C6 C12 linear dicarboxylic acid to said diamine is from 0.97 to 1.06 |
| 03/07/2006 | US7008935 novel sunscreen agents such as Dipotassium Salt of 2-(4-acetamidobenzylidene)malonic Acid or Dipiperidinium Salt of 2-(4-aminobenzylidene)malonic Acid; absorbing within the region of UV-B radiation; cosmetics; photostability, water solubility |
| 03/02/2006 | WO2005120477A3 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators |
| 03/02/2006 | WO2005092305A3 Compounds for treating aids and other diseases |
| 03/02/2006 | WO2005079774A3 Management of ophthalmologic disorders, including macular degeneration |
| 03/02/2006 | WO2005037210A3 Photocleavable isotope-coded affinity tags |
| 03/02/2006 | US20060047171 Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifying and obtaining the polymorphs thereof |
| 03/02/2006 | US20060047141 Method for producing light coloured polyalkylene glycol diethyl ether of fatty acid alcanolamine |
| 03/02/2006 | DE60106241T2 Verwendung von aminverbindungen mit verbesserter bioabbaubarkeit als zusatz für pestizide und düngemittel Use of amine compounds with improved biodegradability as an additional pesticides and fertilizers for |
| 03/02/2006 | DE10218603B4 Verfahren zur Herstellung von hochreinem kristallinem Trichloracetamid aus Hexachloraceton A process for the production of high purity crystalline trichloroacetamide of hexachloroacetone |
| 03/02/2006 | DE102004041531A1 Verfahren zum Herstellen von Biphenylaminen A method for producing biphenyl amines |
| 03/02/2006 | DE102004041496A1 Hydroxybenzoesäureamide und deren Verwendung zur Maskierung von bitterem Geschmack Hydroxybenzoesäureamide and their use for masking of bitter taste |
| 03/02/2006 | DE102004040212A1 New N,N-diacylamine derivatives are useful in the preparation of aromatic and hetero-cyclic aldehydes and useful as acylating or formylating agents |
| 03/01/2006 | EP1628948A1 Difluoromethylbenzanilides and use thereof for combating micro-organisms, intermediate products and use thereof |
| 03/01/2006 | EP1628947A2 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors |
| 03/01/2006 | CN1741984A CaSR antagonist |
| 03/01/2006 | CN1740181A New pirkle-type chiral fixed phase and its prepn process |
| 03/01/2006 | CN1740145A Cinnamide compound synthesizing process |
| 03/01/2006 | CN1740144A Technological process of synthesizing dimethyl acetylamide with methyl acetate and dimethylamine |
| 03/01/2006 | CN1243723C N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 03/01/2006 | CN1243720C Process for producing n-(1-(2,4-dichlorophenyl)ethyl)-2- cyano-3,3-dimethylbutanamide |
| 03/01/2006 | CN1243719C Process for producing N-[1-(2,4. dichlorophenyl) ethyl]-2-cyan-3.3-dimethyl butane amide |
| 02/28/2006 | USRE38995 Interfacial method of preparing ester-substituted diaryl carbonates |
| 02/28/2006 | US7005546 Acetamidobenzamide compounds for neurodegenerative disorders |
| 02/28/2006 | US7005538 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; use to treat cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 02/28/2006 | US7005141 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | WO2006018325A1 Novel biaromatic compounds which activate receptors of ppar type and their use in cosmetic or pharmaceutical compositions |
| 02/23/2006 | US20060041169 Preparation of n-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides |
| 02/23/2006 | US20060041101 Conversion products of mixtures of long-chained fatty acids and aliphatic diamines, and the use thereof |
| 02/23/2006 | US20060041095 Intermediate products, methods for their preparation and use thereof |
| 02/23/2006 | US20060041014 Treatment of male sexual dysfunction |
| 02/23/2006 | US20060040979 3-Aryl-2-hydroxypropionic acid derivative I |
| 02/23/2006 | US20060040869 Pharmaceutically useful compounds |
| 02/23/2006 | US20060039962 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/23/2006 | DE102004039373A1 Para-Alkyl-substituierte N-(4-Hydroxy-3-methoxy-benzyl)-zimtsäureamide und deren Verwendung zur Herstellung von Arzneimitteln Para-alkyl-substituted N- (4-hydroxy-3-methoxy-benzyl) -cinnamic acid amides and their use for the preparation of medicaments |
| 02/23/2006 | CA2576274A1 Para-alkyl-substituted n-(4-hydroxy-3-methoxybenzyl)-cinnamic acid amides and the use thereof for the preparation of medicinal drugs |
| 02/23/2006 | CA2575029A1 Novel biaromatic compounds which activate receptors of ppar type and their use in cosmetic or pharmaceutical compositions |
| 02/22/2006 | EP1627683A2 Metal chelating compositions |
| 02/22/2006 | EP1355912B1 Ligands and their use |
| 02/22/2006 | CN1738795A Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia |
| 02/22/2006 | CN1738613A Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide |
| 02/22/2006 | CN1737005A Chiral diphosphor compound an transition metal complex thereof |
| 02/22/2006 | CN1736980A Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 02/22/2006 | CN1242983C Phenoxyacetic acid derivatives and medicinal compositions containing the same |
| 02/21/2006 | US7002042 Cationic liposomes for gene transfer |
| 02/21/2006 | US7002041 Unsaturated amide (acrylamide or methacrylamide), sulfur-containing compound (thiourea) and a weak acid salt (sodium acrylate); polymerization inhibition |
| 02/21/2006 | US7001921 Cell adhesion inhibitors |
| 02/16/2006 | WO2006016708A1 Fungicidal composition containing acid amide derivative |
| 02/16/2006 | WO2006016219A2 Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases |
| 02/16/2006 | US20060035980 Thyronamine derivatives and analogs and methods of use thereof |
| 02/16/2006 | US20060035113 Lubricant for magnetic recording medium and use thereof |
| 02/16/2006 | DE19632249B4 Verfahren zur Herstellung von Monohydroxyalkylamiden A process for preparing Monohydroxyalkylamiden |
| 02/16/2006 | CA2576009A1 Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases |
| 02/16/2006 | CA2575430A1 1,3-disubstituted heteroaryl nmda/nr2b antagonists |
| 02/16/2006 | CA2572845A1 Formation of tetra-substituted enamides and stereoselective reduction thereof |
| 02/15/2006 | EP1625207A2 Compounds for treatment of inflammation, diabetes and related disorders |
| 02/15/2006 | EP1625138A2 Protected monomers |
| 02/15/2006 | EP1625111A2 Thyronamine derivatives and analogs and methods of use thereof |
| 02/15/2006 | EP1625109A1 Process for the carbonylation of a conjugated diene |
| 02/15/2006 | CN1733708A Anti-hepatitis B virus tertiary amine oxide and preparation method and uses for manufacturing drug |
| 02/15/2006 | CN1733707A Compounds and methods for synthesis and therapy |
| 02/14/2006 | US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |